Vanguard Group Discloses Position in Mural Oncology

The Vanguard Group, Inc. has released a Form 8.3 regarding its holding in Mural Oncology plc, as per the Irish Takeover Panel regulations. The disclosure relates to Vanguard's interests in relevant securities representing 1% or more of Mural Oncology.

As of May 12, 2025, Vanguard holds 772,759 ordinary shares of Mural Oncology, equivalent to a 4.47% interest. This includes recent activity where Vanguard purchased 90 additional shares at $2.64 each.

The form confirms no current agreements, arrangements, or understandings concerning options or derivatives related to Mural Oncology's securities. Furthermore, no supplemental Form 8 is attached, and there's no involvement with any other parties regarding this disclosure.